Your session is about to expire
← Back to Search
Digital Pill + Smartphone Intervention for HIV Prevention in Substance Users (PrEPSteps Trial)
PrEPSteps Trial Summary
This trial will test a new smartphone intervention for people taking PrEP, a daily pill to prevent HIV. The intervention will provide real-time feedback on pill-taking and offer counseling for people who miss doses.
PrEPSteps Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPrEPSteps Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2016 Phase 4 trial • 48 Patients • NCT01529749PrEPSteps Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
For what medical conditions is PrEPsteps most often prescribed?
"While PrEPsteps is most commonly used to treat human immunodeficiency virus type 1 (hiv-1), it can also be taken as a prophylactic measure against hiv transmission and hiv infections more broadly."
Could you please tell us what other similar PrEPsteps studies have been done in the past?
"At this time, 100 clinical trials for PrEPsteps are ongoing with 31 in Phase 3. Most of these trials are based in Boylston, Massachusetts; however, there are 1,581 total locations running these trials."
Would you be able to tell me if this clinical trial is currently open to new participants?
"This is an ongoing clinical trial, which was initially posted on 20th June 2019 as per information on clinicaltrials.gov. The most recent update was on 12th May 2022."
Share this study with friends
Copy Link
Messenger